CAM
ELV icon

Cresset Asset Management’s Elevance Health ELV Stock Holding History

Cresset Asset Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.34M Sell
6,056
-1,191
-16% -$442K 0.01% 620
2026
Q1 		$2.12M Buy
7,247
+963
+15% +$316K 0.01% 547
2025
Q4 		$2.2M Sell
6,284
-77
-1% -$26K 0.01% 539
2025
Q3 		$2.06M Buy
6,361
+100
+2% +$31.1K 0.01% 517
2025
Q2 		$2.44M Sell
6,261
-2,475
-28% -$996K 0.01% 454
2025
Q1 		$3.8M Sell
8,736
-488
-5% -$196K 0.02% 398
2024
Q4 		$3.4M Sell
9,224
-32,802
-78% -$13.7M 0.02% 424
2024
Q3 		$21.9M Buy
42,026
+488
+1% +$261K 0.08% 160
2024
Q2 		$22.5M Buy
41,538
+3,231
+8% +$1.71M 0.09% 148
2024
Q1 		$19.9M Buy
38,307
+1,246
+3% +$620K 0.1% 146
2023
Q4 		$17.5M Buy
37,061
+3,544
+11% +$1.64M 0.1% 134
2023
Q3 		$14.6M Buy
33,517
+8,718
+35% +$3.95M 0.06% 159
2023
Q2 		$11M Buy
24,799
+19,929
+409% +$9.19M 0.01% 249
2023
Q1 		$2.24M Sell
4,870
-5
-0.1% -$2.38K 0.04% 215
2022
Q4 		$2.48M Sell
4,875
-685
-12% -$348K 0.03% 181
2022
Q3 		$2.52M Buy
5,560
+340
+7% +$163K 0.03% 190
2022
Q2 		$2.51M Sell
5,220
-2,095
-29% -$1.04M 0.03% 196
2022
Q1 		$3.59M Sell
7,315
-1,212
-14% -$554K 0.04% 164
2021
Q4 		$3.95M Buy
8,527
+607
+8% +$255K 0.04% 175
2021
Q3 		$2.95M Buy
7,920
+609
+8% +$231K 0.04% 166
2021
Q2 		$2.79M Buy
7,311
+6,103
+505% +$2.33M 0.04% 160
2021
Q1 		$434K Sell
1,208
-5,875
-83% -$1.89M 0.01% 526
2020
Q4 		$2.27M Sell
7,083
-575
-8% -$176K 0.04% 149
2020
Q3 		$2.06M Buy
7,658
+562
+8% +$151K 0.04% 161
2020
Q2 		$1.87M Buy
7,096
+5,420
+323% +$1.45M 0.04% 155
2020
Q1 		$381K Buy
1,676
+710
+73% +$193K 0.01% 340
2019
Q4 		$292K Buy
+966
New +$266K 0.01% 438
2019
Q2 		– Sell
-598
Closed -$172K – 823
2019
Q1 		$172K Buy
598
+183
+44% +$52.9K 0.01% 411
2018
Q4 		$109K Buy
+415
New +$114K 0.01% 311

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Cresset Asset Management's ELV Position: Q2 2026 in Review

Cresset Asset Management reduced its Elevance Health (ELV) stake by 16% in Q2 2026, selling an estimated $442K and leaving 6,056 shares worth $2.34M. The position accounts for 0.01% of the portfolio, ranked #620.

Cresset Asset Management first reported a position in ELV in Q4 2018 and has held it in 29 quarters since. The position peaked at $22.5M in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Cresset Asset Management held 6,056 shares of Elevance Health worth $2.34M as of Q2 2026.
  • Cresset Asset Management sold 1,191 Elevance Health shares in Q2 2026, an estimated $442K.
  • Elevance Health made up 0.01% of Cresset Asset Management's portfolio in Q2 2026, its #620 holding.
  • Cresset Asset Management first reported a position in Elevance Health in Q4 2018 and has held it in 29 quarters since.
  • Cresset Asset Management's Elevance Health position peaked at $22.5M in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.